<DOC>
	<DOCNO>NCT00285727</DOCNO>
	<brief_summary>This 8 week study patient currently take antidepressant medication fully respond . Ropinirole CR would take conjunction current antidepressant medication . Patients come clinic week start medication every week remainder 8 week .</brief_summary>
	<brief_title>Ropinirole Controlled Release ( CR ) Adjunctive Agent Treatment Major Depression</brief_title>
	<detailed_description>We hope learn whether ropinirole CR ( control release formulation ) safe effective take antidepressant reduce symptom depression . Adults diagnosis major depression currently take adequate dose antidepressant medication seek participation . They continue take antidepressant medication receive ropinirole CR , investigational medication , eight week information collect mood cognitive functioning .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<criteria>Age 18 65 year old Currently experience major depression On least adequate dose fluoxetine , paroxetine , sertraline , citalopram , escitalopram , venlafaxine , bupropion , mirtazapine duloxetine least 6 week ( monotherapy ) . 1 . Pregnant female female child bear year use adequate birth control opinion investigator Known sensitivity ropinirole Significant medical condition would preclude safe participation study opinion investigator . Significant abnormality observe screen laboratory evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>